A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma
Clinical trial NCT02328261 · UNKNOWN
Trial details
- NCT number
- NCT02328261
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-10-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.